136 related articles for article (PubMed ID: 15670025)
1. Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system?
Viles-Gonzalez JF; Fuster V
J Thromb Haemost; 2005 Feb; 3(2):230-2. PubMed ID: 15670025
[No Abstract] [Full Text] [Related]
2. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 and restenosis.
Garg N; Fay WP
Curr Drug Targets; 2007 Sep; 8(9):1003-6. PubMed ID: 17896951
[TBL] [Abstract][Full Text] [Related]
4. [Plasminogen activator inhibitor-1 (PAI-1): pathogenetic role in coronary disease].
Młynarska A; Waszyrowski T; Kasprzak JD
Kardiol Pol; 2007 Sep; 65(9):1109-14. PubMed ID: 17975760
[No Abstract] [Full Text] [Related]
5. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
[TBL] [Abstract][Full Text] [Related]
6. Preserved endothelial vasomotion and fibrinolytic function in patients with acute stent thrombosis or in-stent restenosis.
Chia S; Megson IL; Ludlam CA; Fox KA; Newby DE
Thromb Res; 2003; 111(6):343-9. PubMed ID: 14698651
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
[TBL] [Abstract][Full Text] [Related]
8. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
[TBL] [Abstract][Full Text] [Related]
9. Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries.
Kitta Y; Takano H; Nakamura T; Kodama Y; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
Int J Cardiol; 2008 Dec; 131(1):78-82. PubMed ID: 18180052
[TBL] [Abstract][Full Text] [Related]
10. Is IL-10 a predictor of in-stent restenosis in stable and unstable angina patients undergoing coronary interventions?
Karabela G; Karavolias G; Chaidaroglou A; Theleritis C; Degiannis D; Kremastinos D; Adamopoulos S
Int J Cardiol; 2014 Oct; 176(3):1156-7. PubMed ID: 25129273
[No Abstract] [Full Text] [Related]
11. Neopterin as a Marker of In-Stent Restenosis: to Have or Have Not.
Nishihira K
J Atheroscler Thromb; 2018 Nov; 25(11):1089-1090. PubMed ID: 29794395
[No Abstract] [Full Text] [Related]
12. The monocyte: the key in the lock to reduce stent hyperplasia?
Colombo A; Sangiorgi G
J Am Coll Cardiol; 2004 Jan; 43(1):24-6. PubMed ID: 14715177
[No Abstract] [Full Text] [Related]
13. Morphological predictors of restenosis after coronary stenting in humans.
Farb A; Weber DK; Kolodgie FD; Burke AP; Virmani R
Circulation; 2002 Jun; 105(25):2974-80. PubMed ID: 12081990
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of adiponectin, monocyte chemoattractant protein-1, and endothelial function to vascular remodeling in coronary in-stent restenosis].
Wang ZB; Liu J; Chen SY; Su YS; Xie PY; Fang HC
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):912-4. PubMed ID: 20423879
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes.
Osman A; Otero J; Brizolara A; Waxman S; Stouffer G; Fitzgerald P; Uretsky BF
Am Heart J; 2004 May; 147(5):e23. PubMed ID: 15131558
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
Katsaros KM; Speidl WS; Kastl SP; Zorn G; Huber K; Maurer G; Glogar D; Wojta J; Christ G
J Thromb Haemost; 2008 Mar; 6(3):508-13. PubMed ID: 18182031
[TBL] [Abstract][Full Text] [Related]
17. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
[TBL] [Abstract][Full Text] [Related]
18. The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients.
Ortlepp JR; Hoffmann R; Killian A; Lauscher J; Merkelbach-Brese S; Hanrath P
Clin Cardiol; 2001 Sep; 24(9):585-91. PubMed ID: 11558839
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosis.
de Graaf FR; Schuijf JD; van Velzen JE; Boogers MJ; Kroft LJ; de Roos A; Reiber JH; Sieders A; Spanó F; Jukema JW; Schalij MJ; van der Wall EE; Bax JJ
Invest Radiol; 2010 Jun; 45(6):331-40. PubMed ID: 20404736
[TBL] [Abstract][Full Text] [Related]
20. New quantitative method to diagnose coronary in-stent restenosis by 64-multislice computed tomography.
Yoshimura M; Nao T; Miura T; Okada M; Nakashima Y; Fujimura T; Okamura T; Yamada J; Matsunaga N; Matsuzaki M; Yano M
J Cardiol; 2015 Jan; 65(1):57-62. PubMed ID: 24846389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
